Questions & Answers

Click here for a fully formatted PDF version of these Qs & As.

When did tetanus vaccine become available?
The first tetanus toxoid (inactivated toxin) was produced in 1924 and was used successfully to prevent tetanus in the armed services during World War II.

In the mid-1940s, tetanus vaccine was combined with diphtheria toxoid and inactivated pertussis bacteria to make the combination DTP vaccine for routine childhood immunization.

In 1991, DTaP vaccine was licensed in the United States. The pertussis component of this vaccine is a more purified "acellular" version, which produces fewer side effects.

In 2005, two new tetanus toxoid-diphtheria-acellular pertussis (Tdap) vaccines were licensed. These vaccines are the first pertussis-containing vaccines that can be given to persons older than 7 years.

What kind of vaccine is the tetanus toxoid?
The tetanus vaccine is an inactivated toxin (poison) called a toxoid. It is made by growing the bacteria in a liquid medium and purifying and inactivating the toxin. Because it is not a live vaccine, a person's immunity tends to decline with time, which is why booster doses are recommended.

What's the difference between all the vaccines containing tetanus toxoid?
It's like alphabet soup!

Tetanus toxoid is available as a single shot (TT) but it rarely is given that way as it's best to also provide needed protection against other diseases at the same time.

Children younger than age seven years receive DTaP (tetanus, diphtheria, and acellular pertussis). If they cannot receive the pertussis component of the combined vaccine, they can receive DT (diphtheria and tetanus toxoids for pediatric use). DTaP also can be given as part of two different combination vaccines; one includes DTaP, inactivated polio vaccine, and hepatitis B vaccine, and another contains DTaP and Hib vaccine.

Children ages seven years and older and adults should be given a different formulation (i.e., Td or Tdap).

How is this vaccine given?
The DTaP, DT, Td, and Tdap preparations are all given as an injection in the muscle.

Who should get this vaccine?
Infants should receive DTaP vaccine (or DT-pediatric if they cannot receive the pertussis component) as part of their routine immunization. Adults should be given a routine booster dose of Td every 10 years. Adults without documentation of ever receiving the basic series of tetanus and diphtheria toxoids should first receive a primary series of three doses, properly spaced. A single dose of Tdap is recommended for persons age 11 years and older in place of one of the Td doses, preferably the first one.

How many doses of DTaP vaccine are needed?
The usual schedule for infants is a series of four doses given at two, four, six, and 15-18 months of age. A fifth shot, or booster dose, is recommended at 4-6 years of age, unless the fourth dose was given late (after the fourth birthday).

When should adolescents and adults get vaccinated against tetanus? Should they get vaccinated with Td or Tdap?
Immunization experts recommend that the first dose of Tdap be given at age 11-12 as a booster during the routine adolescent immunization visit if the adolescent has finished the childhood DTaP schedule and has not already received a dose of Td or Tdap.

Adults should continue to receive a booster dose of Td every ten years. Adults age 19-64 years who have never received Tdap should receive a single dose of Tdap to replace a single dose of Td so they can boost their resistance to pertussis as well.

If someone experiences a deep or puncture wound, or a wound contaminated with dirt, an additional booster dose may be given if the last dose was more than five years ago. It is important to keep an up-to-date record of all immunizations so that repeat doses don't become necessary. Although it is vital to be adequately protected against tetanus, receiving more doses than recommended can lead to increased local reactions, such as painful swelling of the arm.

Who recommends this vaccine?
The Centers for Disease Control and Prevention (CDC), the American Academy of Pediatrics (AAP), the American Academy of Family Physicians (AAFP), and the American College of Physicians (ACP) all recommend this vaccine.

How safe is this vaccine?
Most children have no serious reactions from the combined DTaP vaccine. The most common reactions are local reactions at the injection site, such as soreness, redness, and swelling, especially after the fifth dose. Other possible reactions may include fussiness, fever, loss of appetite, tiredness, and vomiting. The use of the more purified DTaP instead of DTP has decreased these reactions substantially.

For adults receiving Td vaccine, localized non-serious side effects are common (redness, soreness, etc.) but are generally self-limiting and require no treatment.

What side effects have been reported with this vaccine?
Moderate to serious reactions are uncommon with DTaP vaccine. Such reactions include crying for three hours or more (up to about one child out of 1,000) and high fever (about one child out of 16,000). Most of these side effects are believed to be due to the pertussis component of the vaccine, and a child experiencing such a reaction may still be able to be protected against tetanus and diphtheria with the DT vaccine. More serious reactions, such as seizures, are so rare that it is hard to tell if they are caused by the vaccine.

As mentioned above, adults who received more than the recommended doses of Td vaccine can experience increased local reactions, such as painful swelling of the arm. This is due to the high levels of tetanus antibody in their blood.

The most frequently reported side effects following vaccination with Tdap were headache, generalized body aches, and tiredness.

Some of my patients describe having had a severe reaction to something they were given for tetanus many years ago. What could this be?
The allergic reactions these people experienced may have actually been serum sickness, a reaction to equine antitoxin. Equine antitoxin was the only product available for the prevention of tetanus prior to the mid 1940s. It was used for postexposure prophylaxis until the late 1950s, when tetanus immune globulin was introduced. Tetanus toxoid has never contained any horse protein.

How effective is tetanus-diphtheria toxoid (Td)?
Td is close to 100% effective for persons receiving the correct primary series (as a child or adult) and a routine booster dose every ten years. It is felt that Tdap vaccine will provide the same level of protection.

Who should NOT receive tetanus toxoid?
People who had a serious allergic reaction to one dose of tetanus toxoid should not receive another.

Persons with a moderate or severe acute illness should postpone receiving the vaccine until they are improved. Most reactions to the combined DTaP vaccine are due to the pertussis component. Please see the "Pertussis" section for more information on possible precautions to the use of this vaccine.

Can the vaccine cause tetanus?
No.

Questions and answers about tetanus disease

Technically reviewed by the Centers for Disease Control and Prevention, February 2007